|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 18.00 USD | -2.81% |
|
24.72 | +37.36% |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| 06-10 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 12 | |||||||
| 28 | |||||||
| 19 | |||||||
| 23 | |||||||
| 16 | |||||||
| 31 | |||||||
| 20 | |||||||
| 23 | |||||||
| 26 | |||||||
| 12 | |||||||
| 23 | |||||||
| 5 | |||||||
| 21 | |||||||
| 26 | |||||||
| 9 | |||||||
| 12 | |||||||
| 10 | |||||||
| - | 1 | ||||||
| 10 | |||||||
| - | 1 | ||||||
| Average | 16 | |||||||
| Weighted average by Cap. | 21 |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
